Cardiff, United Kingdom

Fabrizio Pertusati

This inventor holds 4 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Nucana Plc, University College Cardiff Consultants Limited. Active years: 2018-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fabrizio Pertusati. Retrieved from https://idiyas.com/inventor/fabrizio-pertusati

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 2.8

ph-index = 1

Forward Citations = 27(Granted Patents)


Location History:

  • Cardiff, GB (2018 - 2021)
  • Cardiff, IT (2021)
  • Cardiff South Glamorgan, GB (2023)

Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Fabrizio Pertusati

Introduction

Fabrizio Pertusati is a notable inventor based in Cardiff, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticancer compounds. With a total of four patents to his name, Pertusati's work has the potential to impact cancer treatment and related disorders.

Latest Patents

Pertusati's latest patents include innovative compounds that are crucial in the fight against cancer. One of his notable inventions is the "Salts of diphosphate phosphoramidate of nucleosides as anticancer compounds." This invention relates to compounds comprising a salt of a diphosphate phosphoramidate of a nucleoside drug, such as clofarabine. These compounds are particularly useful in treating cancer, including leukemia. Another significant patent involves "Phosphorodiamidates and other phosphorus derivatives of fingolimod and related S1P receptor modulators." These compounds are designed to inhibit class I histone deacetylases and are beneficial in treating lysosomal storage disorders, especially Niemann-Pick type C disease, along with other lysosomal storage disorders and mycobacterial diseases.

Career Highlights

Throughout his career, Fabrizio Pertusati has worked with esteemed organizations, including University College Cardiff Consultants Limited and Nucana Plc. His work in these institutions has allowed him to

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…